Submission Details
| 510(k) Number | K172402 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 09, 2017 |
| Decision Date | October 30, 2017 |
| Days to Decision | 82 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K172402 is an FDA 510(k) clearance for the ARIES Group A Strep Assay, ARIES Group A Strep Assay Protocol File Kit, a Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System (Class II — Special Controls, product code PGX), submitted by Luminex Corporation (Austin, US). The FDA issued a Cleared decision on October 30, 2017, 82 days after receiving the submission on August 9, 2017. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.2680.
| 510(k) Number | K172402 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 09, 2017 |
| Decision Date | October 30, 2017 |
| Days to Decision | 82 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | PGX — Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.2680 |
| Definition | An In Vitro Diagnostic Test For The Detection Of Group A, C And G Beta Hemolytic Streptococcus In Throat Swab Specimens From Symptomatic Patients. |